News/ News/ News/ Oncology/ R&D Bayer bails on $670m CAR-T partnership with Atara Phil Taylor Atara Biotherapeutics, Bayer, CAR-T therapies, immuno-oncology, Oncology, partnering 0 Comment In February, Atara Biotherapeutics paused enrolment into a trial of a CAR-T cell therapy for mesothelioma after a Share X Bayer bails on $670m CAR-T partnership with Atara https://pharmaphorum.com/news/bayer-bails-on-670m-car-t-partnership-with-atara/